James Mahon
Coldingham, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Digital front door technologies to pre-assess people before assessment for NHS Talking Therapies [HTE10055]: early value assessment.
Journal: Health technology assessment (Winchester, England)
Published: June 29, 2026
Estimation of the health economic benefit of widening pulmonary rehabilitation uptake and completion.
Journal: Chronic respiratory disease
Published: December 08, 2024
Clinical equivalence and non-inferiority within health technology assessment.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: November 26, 2024
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.
Journal: Health technology assessment (Winchester, England)
Published: September 10, 2024
Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.
Journal: PharmacoEconomics - open
Published: December 05, 2023
Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
Journal: Health technology assessment (Winchester, England)
Published: October 15, 2023
Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.
Journal: PharmacoEconomics - open
Published: September 03, 2023
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Journal: PharmacoEconomics - open
Published: March 08, 2023
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Journal: PharmacoEconomics - open
Published: February 27, 2023
A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations.
Journal: BMC pulmonary medicine
Published: April 28, 2022
Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation.
Journal: Health technology assessment (Winchester, England)
Published: June 27, 2020
Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Journal: PharmacoEconomics - open
Published: April 16, 2020
Last Updated: 09/26/2026